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佳设计方案如下：PLA 分子量 1 万，浓度 25 mg/mL，初乳超声功率及时间 200 






封率分别达到 1.69%和 62.2%； 
















后，载药微泡 5 d 累积释药量接近 80%；未超声介导下，载药微泡 11 d 累积释药
量接近 80%说明，这种超声介导有助于增加体外药物释放； 
(4) 体外细胞毒性实验证明，载羟基喜树碱－聚乳酸微泡对 Bel-7402 肝癌细
胞的生长和增殖有明显的抑制作用； 

























Cancer is one of chief diseases to threat the health of human being. Chemical 
therapy is an important method to treat it comparing with operation and radial therapy. 
Recently there are more and more researches about microbubbles especially which 
load with drugs and people are focus on the potential of the high therapy of 
microbubbles exposed to ultrasound. 
Hydroxycamptothecin (HCPT) is an antitumor drug that has been used to treat a 
wide range of cancers. And the main medicament of HCPT is lyophilized power. 
Polylactic acid (PLA) is under extensive research because of its unique and excellent 
biocompatibility and biodegradability, particularly in biomedical field. In order to 
increase the plasma drug concentration of the target sites and reduce the amount of 
administration and the toxic effects, we prepare 10-hydroxycamptothecin loaded PLA 
microbubbles and evaluate the bioeffect on hepatocellular carcinoma cells induced by 
ultrasound. 
The main work includes: (1) Evaluation of a number of variables which might 
affect the final microbubbles size, and selection of the optimal level of each variable 
which produced blank microbubbles; (2) Preparation of HCPT-loaded PLA 
microbubbles by an improved solvent evaporation method; (3) Characterization of 
physical and chemical properties of drug-loaded microbubbles; (4) In vitro drug 
release experiments exposed to ultrasound; (5) Cell growth and viability inhibited by 
HCPT-loaded microbubbles in vitro anti-tumor cytotoxicity evaluation; Cellular 
uptake of HCPT when treated with drug-loaded microbubbles in combination with 
ultrasound exposure to Bel-7402 cells. 
The main findings are as follows: (1) Each variable was evaluated sequentially 
by preparing one batch of microbubbles for each level. These optimal levels were: 
PLA concentration of 25 mg/mL, PLA molecular weight of 104, Span80 concentration 
of 2%, ultrasonic power and time of 200 W~80 S and PVA concentration of 1% and 
so on; (2) 10-hydroxycamptothecin (HCPT) loaded PLA microbubbles, used as an 
















evaporation method; The obtained drug-loaded microbubbles were characterized by 
scanning electron microscope (SEM), transmission electron microscope (TEM), x-ray 
diffraction (XRD), differential scanning calorimetry (DSC), confocal laser scanning 
microscope (CLSM) and so on. It was found that the microbubbles showed smooth 
surface and spherical shape, and the drug was amorphously and dispersed within the 
shell and drug loading capacity and encapsulation efficiency reached up to 1.69% and 
62.2%; (3) The cumulative release of HCPT exposed to ultrasound (80 W, 30 S) 
reached more than 80% in 5 days, indicating that even lower ultrasonic intensity could 
produce an increase of drug release from the systems; (4) Cell growth and viability 
was inhibited by HCPT-loaded microbubbles; (5) The bioeffect of diagnostic 
ultrasound exposure (3.5 MHz, 22.57 mW/cm2) on Bel-7402 cells combined with 
HCPT-loaded PLA microbubbles was evaluated using CLSM and flow cytometry 
(FCM). It indicated an increased cellular uptake of HCPT treated with drug-loaded 
microbubbles exposed to ultrasound. 
Preparation of 10-hydroxycamptothecin loaded PLA microbubbles and 
evaluation of the bioeffect on hepatocellular carcinoma cells induced by ultrasound 
will provide useful information for future clinical application. 
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薄而柔软的气泡，直径一般在 2~5 μm 左右，稳定时间长，振动及回波特性好。
该类物质分子量比空气大的多，且为惰性气体，在微球中不易穿过球壁而扩散，
它在血管内停留的时间足以满足实际应用所需要的最大值。最近的文献报道，
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显示出极佳的开发前景。第二代造影剂包括 Optison[12] , PESDA[13] , Sonovue[14] , 
AI-700[15],  Imagent[16]等。 
 
图 1.1 超声造影剂结构图 
(a) 第一代超声造影剂；(b) 第二代超声造影剂 
Fig 1.1 Structural diagram of ultrasound contrast agent 




































加入到含 0.1%棕榈酸的半乳糖粉末中，剧烈摇动 5~10 s，形成牛奶状悬浮液，
微泡直径为 2~4 μm。 
1.1.5.3 机械匀化法 
Unger[19]等制备了 MRX-552 超声造影剂微泡，将紫杉醇混悬于大豆油中，
再加入磷脂混悬液，充以全氟丁烷气体，密封，以 4200 r.min-1 的速度振荡，制





NaCl 混合，加入 10 mL 磷酸盐缓冲液（PH=7.4）研匀。另将 Tween80 与 10 mL
磷酸盐缓冲液研匀，与上液混合，再加入剩余磷酸盐缓冲液混匀。120℃灭菌 15 
min，搅拌至室温。以 20 kHz，110 W 条件下声振处理 3 min。转置于分液漏斗


























































第一章 绪 论 
 6 
定大小的微球（0.1~3 μm）作为异物摄取于肝、脾；较大的微粒（7~30 μm）不
能滤过毛细血管床，被机械截流于肺部；而小于 50 nm 的微球可通过毛细血管
末梢进入骨髓。为使制备的微泡超声造影剂能顺利通过肺部毛细血管而不被滤
过，且能聚集于肝部，微泡的直径最好能控制在 7 μm 以下。 
张志清等[22]制备了平均粒径（13.61±4.80）μm 的依托泊苷白蛋白微球，小
鼠尾静脉注射后 15 min 肺内分布最多，肺内药量占注入总量的（47.88±2.56）%，
其次是肝、心、肾、脾分布较少，除此之外的血液及其它组织仅占注入总量的


























































Chumakova 等 [27]将带负电荷的 PLGA 微泡与正电荷的 PEI/DNA 质粒结合
形成 PLGA/PEI/DNA 微粒，将其经静脉注入体内并施加超声辐照，结果显示其
能增强肿瘤细胞的转染效率。 
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